The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors

What this Trial Is About

This research focuses on children and adolescents with very rare tumors that occur at an annual rate of less than two per million children. These tumors include a wide variety of cancers, some rarely seen at any age and others more typical in adults but rare in pediatric patients. The study aims to gather detailed data to better understand these tumors and how their clinical and biological traits influence treatment outcomes, addressing the current lack of unified diagnostic criteria and information. The study is an international, prospective observational study supported by Padua University Hospital AOUP and the European Reference Network for Paediatric Oncology. It collects epidemiological, clinical, biological, radiological, and treatment data without proposing specific treatments. Collaboration across various European centers allows for comprehensive data collection to improve future diagnosis and treatment recommendations. Participants will be children and adolescents between birth and 18 years old diagnosed or treated for very rare tumors at participating centers. Researchers will collect and analyze data on epidemiology, adherence to international recommendations, and survival outcomes over about one year. The study involves no intervention but monitors participants' clinical progress through data gathering to enhance knowledge and care for rare pediatric cancers.

An International Study on Pediatric Patients With Rare Tumors.